ABBV
AbbVie Inc.
- Operating income, 2025
- $15.1B
- YoY, 2025
- +65.0%
- 5-year CAGR
- +5.8%
- 10-year CAGR
- +7.2%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $15.1B | +65.0% |
| 2024 | $9.1B | −28.4% |
| 2023 | $12.8B | −29.6% |
| 2022 | $18.1B | +1.1% |
| 2021 | $17.9B | +57.7% |
| 2020 | $11.4B | −12.5% |
| 2019 | $13.0B | +103.4% |
| 2018 | $6.4B | −33.1% |
| 2017 | $9.5B | +2.2% |
| 2016 | $9.3B | +23.9% |
| 2015 | $7.5B | +121.0% |
| 2014 | $3.4B | −39.8% |
| 2013 | $5.7B | −2.6% |
| 2012 | $5.8B | +60.7% |
| 2011 | $3.6B | — |